These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 23633409)
1. Outcomes in stage I testicular seminoma: a population-based study of 9193 patients. Beard CJ; Travis LB; Chen MH; Arvold ND; Nguyen PL; Martin NE; Kuban DA; Ng AK; Hoffman KE Cancer; 2013 Aug; 119(15):2771-7. PubMed ID: 23633409 [TBL] [Abstract][Full Text] [Related]
2. Mortality after cure of testicular seminoma. Zagars GK; Ballo MT; Lee AK; Strom SS J Clin Oncol; 2004 Feb; 22(4):640-7. PubMed ID: 14726503 [TBL] [Abstract][Full Text] [Related]
3. Radiotherapy for stage I and II testicular seminomas: Secondary malignancies and survival. Patel HD; Srivastava A; Alam R; Joice GA; Schwen ZR; Semerjian A; Allaf ME; Pierorazio PM Urol Oncol; 2017 Oct; 35(10):606.e1-606.e7. PubMed ID: 28712791 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study. Fung C; Fossa SD; Milano MT; Sahasrabudhe DM; Peterson DR; Travis LB J Clin Oncol; 2015 Oct; 33(28):3105-15. PubMed ID: 26240226 [TBL] [Abstract][Full Text] [Related]
5. Platinum exposure and cause-specific mortality among patients with testicular cancer. Groot HJ; van Leeuwen FE; Lubberts S; Horenblas S; de Wit R; Witjes JA; Groenewegen G; Poortmans PM; Hulshof MCCM; Meijer OWM; de Jong IJ; van den Berg HA; Smilde TJ; Vanneste BGL; Aarts MJB; Jóźwiak K; van den Belt-Dusebout AW; Gietema JA; Schaapveld M Cancer; 2020 Feb; 126(3):628-639. PubMed ID: 31730712 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant carboplatin therapy in patients with clinical stage 1 testicular seminoma: is long-term morbidity increased? Ruf CG; Borck S; Anheuser P; Matthies C; Nestler T; Zecha H; Isbarn H; Dieckmann KP J Cancer Res Clin Oncol; 2019 Sep; 145(9):2335-2342. PubMed ID: 31286241 [TBL] [Abstract][Full Text] [Related]
7. The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis. Powles T; Robinson D; Shamash J; Moller H; Tranter N; Oliver T Ann Oncol; 2008 Mar; 19(3):443-7. PubMed ID: 18048383 [TBL] [Abstract][Full Text] [Related]
8. Outcomes and treatment patterns as a function of time in stage IS testicular seminoma: a population-based analysis. Ahmed KA; Wilder RB Cancer Epidemiol; 2014 Apr; 38(2):124-8. PubMed ID: 24613492 [TBL] [Abstract][Full Text] [Related]
9. Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma. Horwich A; Fossa SD; Huddart R; Dearnaley DP; Stenning S; Aresu M; Bliss JM; Hall E Br J Cancer; 2014 Jan; 110(1):256-63. PubMed ID: 24263066 [TBL] [Abstract][Full Text] [Related]
10. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202 [TBL] [Abstract][Full Text] [Related]
11. Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone. Patterson H; Norman AR; Mitra SS; Nicholls J; Fisher C; Dearnaley DP; Horwich A; Mason MD; Huddart RA Radiother Oncol; 2001 Apr; 59(1):5-11. PubMed ID: 11295200 [TBL] [Abstract][Full Text] [Related]
12. Noncancer causes of death in survivors of testicular cancer. Fosså SD; Gilbert E; Dores GM; Chen J; McGlynn KA; Schonfeld S; Storm H; Hall P; Holowaty E; Andersen A; Joensuu H; Andersson M; Kaijser M; Gospodarowicz M; Cohen R; Pukkala E; Travis LB J Natl Cancer Inst; 2007 Apr; 99(7):533-44. PubMed ID: 17405998 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of radiotherapy for stage II testicular seminoma--the Mayo Clinic experience. Hallemeier CL; Pisansky TM; Davis BJ; Choo R Urol Oncol; 2013 Nov; 31(8):1832-8. PubMed ID: 22537538 [TBL] [Abstract][Full Text] [Related]
14. Stage IIA and IIB testicular seminoma treated postorchiectomy with radiation therapy versus other approaches: a population-based analysis of 241 patients. Ahmed KA; Wilder RB Int Braz J Urol; 2015; 41(1):78-85. PubMed ID: 25928512 [TBL] [Abstract][Full Text] [Related]
15. Stage II Testicular Seminoma: Patterns of Care and Survival by Treatment Strategy. Glaser SM; Vargo JA; Balasubramani GK; Beriwal S Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):513-21. PubMed ID: 27146264 [TBL] [Abstract][Full Text] [Related]
16. Second non-germ cell malignancies in patients treated for stage I-II testicular seminoma. Bachaud JM; Berthier F; Soulié M; Malavaud B; Plante P; Rischmann P; Chevreau C; Daly-Schveitzer N; Grosclaude P Radiother Oncol; 1999 Feb; 50(2):191-7. PubMed ID: 10368043 [TBL] [Abstract][Full Text] [Related]
17. Mortality and cancer incidence following radiotherapy for seminoma of the testis. Horwich A; Bell J Radiother Oncol; 1994 Mar; 30(3):193-8. PubMed ID: 8209001 [TBL] [Abstract][Full Text] [Related]
18. Stage I testicular seminoma: a SEER analysis of contemporary adjuvant radiotherapy trends. Thong AE; Lichtensztajn DY; Almario L; Ingels A; Gomez SL; Gonzalgo ML J Urol; 2013 Oct; 190(4):1240-4. PubMed ID: 23567749 [TBL] [Abstract][Full Text] [Related]
19. Late gastrointestinal morbidity in patients with stage I-II testicular seminoma treated with radiotherapy. Hallemeier CL; Davis BJ; Pisansky TM; Choo R Urol Oncol; 2014 May; 32(4):496-500. PubMed ID: 24332645 [TBL] [Abstract][Full Text] [Related]
20. [Radiotherapy of testicular seminoma: changes over the past 10 years]. Mirimanoff RO Cancer Radiother; 2003 Nov; 7 Suppl 1():70s-77s. PubMed ID: 15124547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]